Schedule 13G ownership disclosure

Evofem Biosciences Operations, Inc.

Security class unavailable · CUSIP: 30048L104

Event date: 2022-08-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-217375
Form type
SC 13G/A
Filer
Cox Todd Stewart
CIK
CIK 1938465
Filed
Aug 10, 2022
Reporting period
Aug 09, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub